| Index | — | P/E | 18.93 | EPS (ttm) | 4.26 | Insider Own | — | Shs Outstand | 556.03M | Perf Week | 1.43% |
| Market Cap | 44.83B | Forward P/E | 18.33 | EPS next Y | 4.40 | Insider Trans | — | Shs Float | 555.86M | Perf Month | 2.62% |
| Enterprise Value | 30.39B | PEG | 2.28 | EPS next Q | 0.74 | Short Float | 0.72% | Perf Quarter | -1.99% | ||
| Income | 2.59B | P/S | 1.41 | EPS this Y | 7.16% | Short Ratio | 5.46 | Perf Half Y | 11.77% | ||
| Sales | 31.88B | P/B | 2.38 | EPS next Y | 7.64% | ROA | 0.84% | Short Interest | 4.03M | Perf YTD | 29.21% |
| Book/sh | 33.84 | P/C | 2.15 | EPS next 5Y | 8.30% | ROE | 13.89% | 52W High | 84.38 -4.44% | Perf Year | 31.99% |
| Cash/sh | 37.51 | P/FCF | 5.84 | EPS past 3/5Y | 5.41% 7.69% | ROIC | 0.85% | 52W Low | 57.22 40.91% | Perf 3Y | 77.52% |
| Dividend Est. | 2.77 (3.43%) | EV/EBITDA | 8.08 | Sales past 3/5Y | 125.39% -1.34% | Gross Margin | 36.56% | Volatility | 1.30% 1.37% | Perf 5Y | 41.16% |
| Dividend TTM | 2.71 (3.36%) | EV/Sales | 0.95 | EPS Y/Y TTM | 5.49% | Oper. Margin | 11.21% | ATR (14) | 1.21 | Perf 10Y | 143.01% |
| Dividend Ex-Date | Aug 26, 2026 | Quick Ratio | 27.38 | Sales Y/Y TTM | 13.23% | Profit Margin | 8.81% | RSI (14) | 55.64 | Recom | 2.93 |
| Dividend Gr. 3/5Y | 5.66% 6.90% | Current Ratio | 27.38 | EPS Q/Q | 13.18% | SMA20 | 2.00% | Beta | 0.82 | Target Price | 88.00 |
| Payout | 59.57% | Debt/Eq | 0.34 | Sales Q/Q | 51.44% | SMA50 | 1.62% | Rel Volume | 0.43 | Prev Close | 80.91 |
| Employees | 32,151 | LT Debt/Eq | 0.34 | Earnings | Nov 04 | SMA200 | 9.72% | Avg Volume | 696.86K | Price | 80.63 |
| IPO Date | Mar 23, 2000 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 6.94% — | Net Debt/EBITDA | -3.84 | Volume | 297,349 | Change | -0.35% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-03-26 | Reiterated | Argus Research | Buy | $81 → $88 |
| Jun-10-26 | Reiterated | Argus Research | Buy | $70 → $81 |
| Nov-10-25 | Downgrade | RBC Capital | Outperform → Sector Perform | |
| Oct-07-25 | Reiterated | Morgan Stanley | Equal Weight | $88 → $89 |
| Nov-14-24 | Reiterated | Capital One Financial | $92 | |
| Oct-04-21 | Reiterated | Stifel Nicolaus | $74 | |
| Aug-05-21 | Reiterated | Barclays | Underweight | $64 |
| Mar-14-19 | Downgrade | CIBC | Neutral → Underperform | |
| Feb-06-19 | Downgrade | Scotiabank | Sector Outperform → Sector Perform | |
| May-05-18 | Downgrade | Argus | Buy → Hold |
Sun Life Financial Inc. operates as a global financial institution, delivering a wide range of insurance, wealth management, and asset accumulation services to both individual and corporate clients worldwide. Its offerings encompass diverse life insurance products, including term and whole life policies, in addition to personal health, dental, critical illness, long-term care, and disability coverage. The company also engages in reinsurance activities, provides investment advisory and portfolio management services, and administers mutual and segregated funds. Furthermore, it offers trust and banking solutions, along with real estate brokerage, appraisal, and merchant banking services. Its distribution network is extensive, utilizing direct sales representatives, various general agents (both managing and independent), financial intermediaries, broker-dealers, banking institutions, pension and benefits consultants, and other external marketing organizations. Founded in 1871, the firm's headquarters are located in Toronto, Canada.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 31,881 | 30,181 | 25,175 | 26,943 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 20,678 | 0 | 21,641 | 23,747 | — | — | — | — | — | |
| Gross Profit | 11,202 | 30,181 | 3,534 | 3,197 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1,946 | 0 | 0 | 0 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 5,808 | 26,750 | 366 | 284 | — | — | — | — | — | |
| Operating Income | 3,449 | 3,431 | 3,168 | 2,913 | — | — | — | — | — | |
| Interest Expense | 404 | 376 | 485 | 409 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 255 | 376 | 485 | 409 | — | — | — | — | — | |
| Net Income Before Taxes | 3,300 | 3,431 | 3,168 | 2,913 | — | — | — | — | — | |
| Income Taxes | 696 | 727 | 759 | 342 | — | — | — | — | — | |
| Consolidated Net Income | 2,593 | 2,678 | 2,315 | 2,478 | — | — | — | — | — | |
| Net Income From Continuing Operations | 2,605 | 2,705 | 2,408 | 2,571 | — | — | — | — | — | |
| Net Income | 2,593 | 2,678 | 2,315 | 2,478 | — | — | — | — | — | |
| EPS (Recurring) | 4.28 | 4.41 | 3.86 | 3.88 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 4.28 | 4.41 | 3.86 | 3.88 | — | — | — | — | — | |
| EPS (Diluted) | 4.26 | 4.40 | 3.85 | 3.88 | — | — | — | — | — | |
| EBITDA | 3,763 | 3,807 | 3,653 | 3,322 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 18.93 | 14.18 | 15.42 | 13.35 | — | — | — | — | — | |
| Price To Sales Ratio | 1.40 | 1.18 | 1.36 | 1.13 | — | — | — | — | — | |
| Gross Margin | 35.14 | 100.00 | 14.04 | 11.87 | — | — | — | — | — | |
| Operating Margin | 10.82 | 11.37 | 12.58 | 10.81 | — | — | — | — | — | |
| Net Margin | 8.13 | 8.87 | 9.20 | 9.20 | — | — | — | — | — | |
| Shares Outstanding | 554 | 573 | 578 | 589 | — | — | — | — | — | |
| Market Capitalization | 44,669 | 35,755 | 34,299 | 30,546 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |